Park Medi World Limited (PARKHOSPS.NS)
NSE · INR · Healthcare · Medical Care Facilities
₹229.70 (+4.58%) as of
Key statistics
- Market cap
- 99.21B
- P/E (TTM)
- 34.96
- Forward P/E
- 21.67
- EPS (TTM)
- 6.57
- Dividend yield
- 0.00%
- 52-week range
- 138.10 – 305.00
- Revenue (TTM)
- 17.56B
- Profit margin
- 16.09%
- Analyst target
- ₹362.50
- Volume
- 680.28k
About Park Medi World Limited
Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paediatrics, internal medicine and geriatrics, rheumatology, ENT, ophthalmology, obstetrics and gynaecology, interventional radiology and imaging, psychiatry, pathology and microbiology, paediatric surgery, fertility management, nuclear medicine services. It operates NABH accredited multi-super specialty hospitals under the Park brand name. Park Medi World Limited was founded in 2005 and is headquartered in Gurugram, India.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Gurugram, India
- Employees
- 6,423
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.